Dr. Romero Marrero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7369 Sheridan St
Ste 300
Hollywood, FL 33024Phone+1 954-451-5932- Is this information wrong?
Summary
- Dr. Carlos Romero-Marrero is a Staff Physician in the Digestive Disease and Surgical Institute of the Cleveland Clinic. He specializes in diagnosing and treating people with gastrointestinal and liver diseases. He completed his medical school, residency and Gastroenterology Fellowship in the University of Puerto Rico. He subsequently completed advanced training in liver transplantation at the Mayo Clinic. He has been at the Cleveland Clinic for the past 5 years. He is the Associate Program Director of the Gastroenterology Fellowship and co-leads SALUD, the Hispanic Employee Group of the Cleveland Clinic. He is also a staff physician at the Hispanic Clinic of Cleveland Clinic Lutheran Hospital.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2009 - 2010
- University of Puerto RicoFellowship, Gastroenterology, 2005 - 2009
- University of Puerto RicoM.Sc., Clinical Research, 2005 - 2007
- University of Puerto RicoResidency, Internal Medicine, 2001 - 2004
- University of Puerto Rico School of MedicineClass of 2001
- University of Massachusetts AmherstB.S., Biology, 1993 - 1997
Certifications & Licensure
- FL State Medical License 2020 - 2025
- OH State Medical License 2011 - 2024
- MN State Medical License 2009 - 2011
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
- AOA Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Senior Fellows Teacher of the Year Award Gastroenterology Fellowship Program, Cleveland Clinic, 2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Alpha Omega Alpha University of Puerto Rico House Staff Inductee, 2008
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsStatin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review.Shrouq Khazaaleh, Muhammad Talal Sarmini, Mohammad Alomari, Laith Al Momani, Bara El Kurdi, Mohammad Asfari, Zain Almomani, Carlos Romero-Marrero> ;Cureus. 2022 Jul 1
- 2 citationsGastrointestinal Toxicities of Immune Checkpoint Inhibitors Are Associated With Enhanced Tumor Responsiveness and Improved Survival.Mohammad Alomari, Suleiman Al Ashi, Pravallika Chadalavada, Shrouq Khazaaleh, Fahrettin Covut, Laith Al Momani, Ahmed Elkafrawy, Vinay Padbidri, Pauline Funchain, Dona...> ;Gastroenterology Research. 2022 Apr 1
- 1 citationsRisk of hernia-related complications after transjugular intrahepatic portosystemic shunt creation in patients with pre-existing ventral abdominal hernias: 15-year expe...Charles McDaniel, Ruth Bell, Natalie Farha, Catherine Vozzo, Jennifer Bullen, Michael Rosen, Carlos Romero-Marrero, Sasan Partovi, Baljendra Kapoor> ;BMJ Open Gastroenterology. 2022 Mar 1
- Join now to see all
Journal Articles
- A New Clinically Based Staging System for Perihilar CholangiocarcinomaRoongruedee C, Harmsen WS, Romero-Marrero C, Aboelsoud MM, Ndzengue A, Kaiya J, Therneau T, Sanchez W, Gores G, Roberts LR, Am J Gastroenterol, 1/1/2014
- Outcomes of an underserved Hispanic population with chronic Hepatitis C treated with Pegylated interferon and Ribavirin in a government-sponsored clinicIturrino J, Sanchez CJ, Ortiz A, Romero CJ, Velazquez V, Costas PJ, and Torres EA, P R Health Sci J, 1/1/2011
- Incidence and mortality rates of selected infection related cancers in Puerto Rico and in the United StatesOrtiz AP, Soto-Salgado M, Calo WA, Tortolero-Luna G, Perez CM, Romero CJ, Perez J, Figueroa N, Suarez E, Infectious Agents and Cancer, 1/1/2010
- Join now to see all
Abstracts/Posters
- Etiology, Model for End-Stage Liver Disease and Hospitalization Requiring Intensive Care are Predictors of 30-day Readmission in Patients with Liver DiseaseAgito, Markus MD, Ghobrial, Michael MD, Lopez, Rocio MS, Atreja, Ashish MD MPH, Romero-Marrero, Carlos MD, Rizk, Maged K MD, Clinical Research Workshop, AASLD, 1/1/2012
- Adherence to Recommendations in the Use of Albumin for Patients with Spontaneous Bacterial Peritonitis not Optimal and Can Reduce 30-day ReadmissionThomas Smith; Rohit Makkar; Rocio Lopez; Maged K. Rizk; Carlos J. Romero-Marrero, AASLD, 1/1/2012
- Molecular Pathogenesis of CholangiocarcinomaRomero Marrero C, Roberts LR, 20th Conference of the Asian Pacific Association for the Study of the Liver, Beijing, China, 1/1/2010
- Join now to see all
Lectures
- Predicting Mortality in Patients With Cirrhosis Admitted to Intensive Care Units: A Comparison of Current ModelsSan Diego, CA - 1/21/2016
- Predicting Mortality in Patients After Liver Transplantation: A Calibrated Prognostic Model for Patients in the Post-Operative PeriodSan Diego, CA - 1/21/2016
- Predicting Mortality in Patients with Cirrhosis Admitted to Intensive Care Units: A Novel Prognostic ModelBoston, MA - 1/11/2016
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Hospital Affiliations
- Cleveland Clinic Martin North HospitalStuart, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: